Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
H.I.G. Capital is a leading global alternative investment firm with approximately $70 billion in assets under management, focusing on the mid-cap segment across private equity, growth equity, real estate, direct lending, infrastructure, special situations debt—and notably growth-stage healthcare and life sciences. The company has invested in over 400 companies since its founding in 1993 and currently manages a diverse global portfolio spanning multiple industries including healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on H.I.G. Capital.